Charles River Laboratories International, Inc. (NYSE:CRL) headquartered in Wilmington, will host a conference call for the investment community to discuss the 3Q20 earnings result on 29th October 2020 at 9:30 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.criver.com
Earnings Expectation
Charles River Laboratories International, Inc. is expected to report third quarter earnings results, before market open, on Thursday 29th October 2020. Analysts polled by Thomson Reuters anticipate third quarter income of $ 1.80 per share from revenue of $ 716.88 million. Looking ahead, the full year income are expected at $ 7.26 per share on the revenues of $ 2851.89 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 2,817.58 million ~ $ 2,857.00 million, where as bottomline are predicted in a range of $ 7.05 ~ $ 7.35 per share
Click Here For More Historical Outlooks Of Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily purpose-bred rats and mice for use by researchers.
